Arena Pharmaceuticals, Inc. (ARNA) Posts Q3 Loss of 7c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. CRGY
7. AAPL
8. SPY
9. APLD
10. ORCL

Go back to Arena Pharmaceuticals, Inc. (ARNA) Posts Q3 Loss of 7c/Share

Jefferies Remains Bullish on Arena Pharma (ARNA) But Tempers Valuation Target on Data from Rival

November 7, 2012 11:26 AM EST

Jefferies cut its price target on Arena Pharma (NASDAQ: ARNA) from $20 to $14 following the company's Q3 results and conference call, but maintained a Buy rating on the long-term potential for Belviq.

"ARNA reiterated its plans for Belviq (1Q13 U.S. launch) and... More